Endocrinology 16 - Type 2 Diabetes Mellitus Flashcards

1
Q

Define diabetes mellitus

A

Diabetes mellitus can be defined as a state of chronic hyperglycaemia sufficient to cause long-term damage to specific tissues, notably the retina, kidney, nerves, and arteries

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

List the main characteristics of T2DM

A
  • Not ketosis prone
  • Not mild
  • Often involves weight, lipids and blood pressure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe the epidemiology of T2DM

A
  • Diabetes 10% at 60 years (4-7% T2DM)
  • Increasing age, but now seen in children
  • Varies enormously, but is increasing
  • Occurring and being diagnosed younger
  • Greatest in ethnic groups that move from rural to urban lifestyle
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe pathophysiology of T2DM

A
  • MODY (uncommon but useful insights)
  • Genes and intrauterine environment, as well as adult environment
  • Insulin resistance and secretion defects
  • Fatty acids important in pathogenesis and complications
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is maturity onset diabetes of the young?

A
  • Several hereditary forms
  • Autosomal dominant
  • Ineffective pancreatic B cell insulin production
  • Mutations of transcription factor genes, glucokinase gene
  • Positive FH, no obesity
  • Specific treatment for type
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe the onset and progression of T2DM

A
  • Genes (more insulin needs to be produced their whole life, low insulin in the fetus, obesity in the adult)
  • Dyslipidaemia caused by insulin resistance adipocytokines
  • Insulin resistance and eventual B cell failure and insulin secretion deficit
  • Increased hyperglycaemia and dyslipidaemia due to B cell failure
  • Acute and chronic complications. May eventually need insulin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How important is obesity in T2DM?

A
  • More than a precipitant
  • Fatty acids and adipocytokines important
  • Central or omental particularly (drain directly to the liver)
  • 80% T2DM obese at diagnosis
  • Weight reduction is useful to adress in treatment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How do gut bacteria relate to T2DM?

A
  • Fatty acids released by the biome could enter the circulation and alter liver metabolism. Local fermentation of fatty acids
  • More important in obesity association than diabetes
  • Alter our signalling
  • Alter inflammation and metabolic pathways
    (correlative not causative at the moment)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How does T2DM present?

A
  • Heterogenous
  • Obesity
  • Insulin resistance and secretion deficit
  • Hyperglycaemia and dyslipidaemia
  • Osmotic symptoms
  • Screening test

Acute and chronic complications

  • Infections (due to high sugar)
  • Hyperosmolar coma (acute complications)
  • Ischaemic heart disease or retinopathy (chronic complications)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

List the complications of T2DM

A

Microvascular

  • Retinopathy
  • Nephropathy
  • Neuropathy

Metabolic

  • Lactic acidosis
  • Hyperosmolar

Macrovascular

  • Ischaemic heart disease
  • Cerebrovascular
  • Renal artery stenosis
  • PVD
  • Hypoglycaemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How is T2DM managed?

A
  • Education
  • Diet
  • Pharmacological treatment
  • Complication screening
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Why does T2DM need to be treated?

A
  • Symptoms
  • Reduce chance of acute metabolic complications
  • Reduce change of long term contributions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How do patients with T2DM need to eat?

A
  • Control calories and increase exercise
  • Reduce refined carbohydrate
  • Increase complex carbohydrate
  • Reduce fat as a proportion of calories
  • Increase unsaturated fat as a proportion of fat
  • Increase soluble fibre
  • Address salt
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How is T2DM treated and monitored?

A
  • Weight
  • Glycaemia
  • Blood pressure
  • Dyslipidaemia
  • Gasric bypass
  • Metformin
  • Acarbose
  • Thiazolidinediones
  • GLP-1
  • Empaglifoxin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the effects of metformin?

A
  • Insulin sensitiser
  • Used in overweight patients where diet has not succeeded
  • Reduces insulin resistance
  • GI side effects
  • DO NOT USE if liver, cardiac or mild renal failure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is acarbose, how does it work and are there any side effects?

A
  • Alpha glucosidase inhibitor
  • Prolongs absorption of oligosaccharides
  • Allows insulin secretion to cope, following defective first phase insulin
  • As effective as metformin
  • Side effects flatus
17
Q

What are thiazolidinediones? List the effects

A
  • Peroxisome proliferator-actived receptor agonists (PPAR-γ)
  • eg. Pioglitazone
  • Insulin sensitizer, mainly peripheral
  • Adipocyte differentiation modified, weight gain but peripheral not central
  • Improvement in glycaemia and lipids
  • Evidence base on vascular outcomes
18
Q

What is GLP-1, and what are its actions?

A
  • Secreted in response to gut nutrients
  • Transcription product of proglucagon gene, mostly from L cell.
  • Stimulates insulin, suppresses glucagon
  • Increases satiety
  • Restores B cell glucose sensitivity
  • Short half life, rapid degredation from enzyme dipeptidyl peptidase-4 (DPPG-4 inhibitor)
19
Q

List the GLP-1 agonists and their uses

A
  • Exenatide and liraglutide
  • Injectable
  • Long acting GLP-1 agnosit
  • Decrease glucagon
  • Decrease glucose
  • Weight loss
20
Q

List the uses of Gliptins

A
  • DPPG-4 inhibitor (oral)
  • Increase half life of exogenous GLP-1
  • Increase GLP-1
  • Decrease glucagon and glucose
  • Neutral effect on weight
21
Q

What is empaglifozin? List its effects.

A
  • Used in T2DM patients
  • Inhibits Na-Glu transporter in the proximal convoluted tubule (SGLT-2)
  • Increases glucosuria
  • HbA1c lower
  • 32% lower all cause mortality
  • 35% lower risk heart failure
22
Q

What should be controlled as well as weight in T2DM?

A
  • Blood pressure

- Diabetic dyslipidaemia (high cholesterol and triglyceride, low HDL-cholesterol)

23
Q

How does fetal and infant weight affect diabetes?

A
  • Weight at one year less than 8kg increases risk of diabetes or impaired glucose tolerance
  • Low protein intrauterine increases risk of diabetes due to impaired pancreatic development
24
Q

What happens to insulin secretion and insulin resistance as we age?

A
  • Insulin secretion decreases as we age

- Insulin resistance increases as we age

25
Q

Why does dyslipidaemia occur in T2DM?

A
  • Triglycerides broken down to glycerol and non esterified fatty acids
  • NEFAs are converted to very low density lipoproteins
  • Glycerol is used to produce more glucose in the liver (gluconeogenesis)
26
Q

What is important in insulin resistance and decreased decretion?

A
  • Exercise and diet
  • Genes
  • Split pro-insulin
  • Microbiome
  • Adiopocytokines
  • Intrauterine enviroment
27
Q

What is orlistat?

A
  • Intestinal lipase inhibitor
  • Fat we have eaten is not absorbed and passes into the faeces instead
  • Used for weight loss
28
Q

What is sibutramine?

A
  • Reuptake noradrenaline to affect energy use
  • Previously used for weight loss
  • Not used anymore
29
Q

How do sulphanylureas work?

A
  • Stimulate release of insulin from B cells of the pancreas
  • Does this by binding to and closing ATP sensitive potassium channels in the cell membrane (causes depolarisation by preventing K+ entering the cell, opening VGCCs)
  • Requires presence of functional B cells
30
Q

List the drugs used in diabetes treatment

A
  • Suphanylureas (eg. glibenclamide)
  • DPP4 inhibitors (gliptins)
  • GLP-1 agonists
  • Metformin
  • Acarbose (glucosidase inhibitor
  • Thisalidinediones (eg. pioglitazone)
  • SGLT-2 inhibitors (empaglifozin)
31
Q

What are the side effects of sulphonylureas?

A
  • Hypoglycaemia

- Weight gain